SCHEMBL3790353

SCHEMBL3790353

NC(=O)c1ccc(N)cc1-c1cccc(N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.48
PARP1 P09874 1/20 0.48
PLK4 O00444 1/20 0.48
EGFR P00533 1/20 0.48
ROS1 P08922 1/20 0.48
PIM1 P11309 1/20 0.48
AXL P30530 1/20 0.48
FLT3 P36888 1/20 0.48
FRK P42685 1/20 0.48
MAP4K2 Q12851 1/20 0.48
NTRK3 Q16288 1/20 0.48
MINK1 Q8N4C8 1/20 0.48
AURKB Q96GD4 1/20 0.48
HIPK2 Q9H2X6 1/20 0.48
MKNK2 Q9HBH9 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.48
STK17A Q9UEE5 1/20 0.48
ALK Q9UM73 1/20 0.48
BCAT2 O15382 1/20 0.47
PLA2G2A P14555 9/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29771744 0.95 BCAT2 (0.48) MAP4K4PARP1PLK4EGFRROS1
SCHEMBL21295924 0.88 PLA2G2A (0.47) MAP4K4PARP1PLK4EGFRROS1
SCHEMBL31151826 0.87 MAP4K4 (0.49) MAP4K4PARP1PLK4EGFRROS1
SCHEMBL3784596 0.87 BCAT2 (0.63) BCAT2PLA2G2APLA2G10RORCRORB
SCHEMBL27769904 0.87 MAP4K4 (0.44) MAP4K4PARP1PLK4EGFRROS1
SCHEMBL9185623 0.86 MCL1 (0.58) MAP4K4PLA2G2AMCL1RORCRORB
SCHEMBL1456885 0.86 BCAT2 (0.67) MAP4K4PARP1PLK4EGFRROS1
SCHEMBL3792146 0.86 MAP4K4 (0.48) MAP4K4PARP1PLK4EGFRROS1
SCHEMBL29203839 0.85 BCAT2 (0.48) BCAT2PLA2G2APLA2G10MCL1IKBKB
SCHEMBL3808754 0.84 MCL1 (0.45) MAP4K4MCL1RORCRORBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107880802-A polyimide film with adhesive 杜邦-东丽株式会社 2018-04-06 CN disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAP4K4 3704/4885PARP1 3661/4885PLK4 3139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.